Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...
IRVINE, Calif., June 17 NeoMend, Inc. today announced thatits ProGEL(TM) Surgical Sealant has received a recommendation for approvalfrom the U.S. Food and Drug Administration's (FDA) Anesthesiology ...
IRVINE, Calif.--(BUSINESS WIRE)--Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received the European Union CE Mark for the ...
NeoMend, a biotech company based in Irvine, California, has raised $6 million in a Series C round from an undisclosed VC, reports vw. Existing investors Prospect Venture Partners and Sanderling ...
Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...
Renowned medical devices maker CR Bard ( BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results